Fingerprint
Dive into the research topics of 'Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1
Sant P. Chawla, Brian A. Van Tine, Seth M. Pollack, Kristen N. Ganjoo, Anthony D. Elias, Richard F. Riedel, Steven Attia, Edwin Choy, Scott H. Okuno, Mark Agulnik, Margaret Von Mehren, Michael B. Livingston, Vicki L. Keedy, Claire F. Verschraegen, Tony Philip, G. Chet Bohac, Sergey Yurasov, Adam Yakovich, Hailing Lu, Michael Chen
Research output: Contribution to journal › Article › peer-review